Abstract:BackgroundHepatocellular carcinoma (HCC) is the most commonly diagnosed malignancy of the liver, occurs frequently in the setting of chronic liver injury. Although multiple therapeutic approaches are available, the prognosis of patients with HCC remains poor. Dioscin is a natural steroid saponin that presents in various plants. The anti-cancer and anti-fibrotic effects have been extensively reported. However, the effect of dioscin on HCC remains unclear. We aimed to investigate the anti-HCC properties of dioscin in vitro and in vivo.MethodsMTT (3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl-tetrazolium bromide) assay was used to analyze the growth inhibition activity of Dioscin in human cell lines, Bel-7402, HepG2, Lovo, and EAhy926. Antitumor activity through induction of apoptosis was evaluated by flow cytometry using Annexin-V and propidium iodide (PI) staining, laser scanning confocal microscopy (LSCM) analysis with Hochest33342 and PI labeling, and DNA fragmentation analysis. The expression of apoptosis-related proteins tumor protein p53 (TP53), BCL2-associated X protein (BAX), B-Cell CLL/Lymphoma 2 (BCL2) and Caspase 3 (CASP3) was measured by Western blot. Nude mice bearing Bel-7402 were administered intraperitoneally at different doses of dioscin and 5-FU (5-Fluorouracil) treatment was used as a control. Tumor volume and tumor weight of each mouse were then measured.ResultsWe demonstrated that Dioscin inhibited proliferation of HCC cell lines in a dose-dependent manner. Dioscin also significantly induced morphological changes during death by apoptosis and increased DNA damage of Bel-7402 cells. Moreover, we demonstrated that Dioscin displayed anticancer activity via up-regulating expression of TP53, BAX and CASP3 protein, as well as down-regulating BCL2 in Bel-7402 cells. Notably, the in vivo anticancer activity of Dioscin was further assessed and achieved greater inhibition efficiency at the concentration increased to 24mg/kg/day than 5-FU at dose of 10mg/kg/day in nude mice bearing Bel-7402 cells.ConclusionsDioscin inhibited tumor growth via inducing apoptosis, which was accompanied by altered expression of apoptotic pathway proteins, such as TP53, BAX, BCL2 and CASP3. Our findings indicate that further evaluation of dioscin as a novel therapeutic approach for HCC is warranted.

Dioscin Inhibits Colon Tumor Growth and Tumor Angiogenesis Through Regulating VEGFR2 and AKT/MAPK Signaling Pathways

Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer Via Promoting C-Myc Ubiquitination and Subsequent Hexokinase-2 Suppression

Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin

Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis

Dioscin inhibits human endometrial carcinoma proliferation via G0/G1 cell cycle arrest and mitochondrial-dependent signaling pathway

Dioscin Suppresses Hepatocellular Carcinoma Tumor Growth by Inducing Apoptosis and Regulation of TP53, BAX, BCL2 and Cleaved CASP3.

Impact and mechanism study of dioscin on biological characteristics of colorectal cancer cells

Dioscin Inhibits Stem-Cell-like Properties and Tumor Growth of Osteosarcoma Through Akt/GSK3/β-catenin Signaling Pathway

Dioscin Promotes Prostate Cancer Cell Apoptosis and Inhibits Cell Invasion by Increasing SHP1 Phosphorylation and Suppressing the Subsequent MAPK Signaling Pathway

Anti-cancer Effects and Mechanisms of Diosmin in HepG2 Cells in Vitro Revealed by Network Pharmacology and Molecular Docking

Dioscin Facilitates ROS-induced Apoptosis Via the P38-Mapk/hsp27-mediated Pathways in Lung Squamous Cell Carcinoma

Integrated miRNA and mRNA omics reveal dioscin suppresses migration and invasion via MEK/ERK and JNK signaling pathways in human endometrial carcinoma in vivo and in vitro

Study on the Mechanism of Diosgenin Targeting STAT3 to Inhibit Colon Cancer Proliferation and Migration

Connexin 43 upregulation by dioscin-inhibited gastric cancer metastasis by suppressing PI3K/Akt pathway

Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins.

Diosgenin exerts anti-tumor effects through inactivation of cAMP/PKA/CREB signaling pathway in colorectal cancer

Anticancer Activity of Diosgenin and Its Molecular Mechanism

Dioscin Induces M1 Macrophage Polarization Through Connexin-43 Channels in Tumor-associated-macrophages-mediated Melanoma Metastasis

Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line.

Dioscin Induces Gallbladder Cancer Apoptosis By Inhibiting Ros-Mediated Pi3k/Akt Signalling

Diosgenin Exerts Its Tumor Suppressive Function Via Inhibition of Cdc20 in Osteosarcoma Cells